Načítá se...

Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin.

Eleven patients with chronic inflammatory arthritides and haemoglobin concentrations less than 105 g/l with symptoms from their anaemia were treated with a dose of 250 IU/kg/week of recombinant human erythropoietin for six weeks. The treatment was given as subcutaneous injections five days a week. A...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Gudbjörnsson, B, Hällgren, R, Wide, L, Birgegård, G
Médium: Artigo
Jazyk:Inglês
Vydáno: 1992
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1004739/
https://ncbi.nlm.nih.gov/pubmed/1616357
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!